---
AWKN-SDN-14

About AWKN-SDN-14

Overview:

AWKN-SDN-14 are a series of serotonin, dopamine, and noradrenaline modulators under pre-clinical investigation by Awakn. Being assessed for potential to promote pro-social behavior and offer an improved safety profile compared to existing treatments being developed for PTSD.

Pro-social behavior is increasingly recognised as a key factor in addressing PTSD. Enhancing these behaviors may help individuals with PTSD overcome feelings of isolation, rebuild interpersonal relationships, and engage more effectively in therapeutic interventions.

Intellectual Property :

Composition of matter patents filed internationally by Awakn

Sign Up for Newsletter

MAIN OFFICE
Awakn Life Sciences Corp
301-217 Queen St. W
Toronto, Ontario M5V 0R2
Canada

© 2023 Awakn Life Sciences Corp      |      Privacy Policy      |      Disclaimer